Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 4Prostatic Neoplasms 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Neoplasms 3Urinary Bladder Neoplasms 2Rectal Neoplasms 2Hematologic Neoplasms 2Colorectal Neoplasms 2Anatomic Stage I Breast Cancer AJCC v8 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Stomatitis 1Stomach Neoplasms 1Sarcoma 1Recurrence 1Radiodermatitis 1Papillomavirus Infections 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Multiple Endocrine Neoplasia Type 1 1Melanoma 1Lung Neoplasms 1Localized Prostate Carcinoma 1Leukemia, Myeloid, Acute 1Hepatitis B 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Endometrial Clear Cell Adenocarcinoma 1Disease Progression 1

Interventions

tenofovir alafenamide 1human papillomavirus vaccine, L1 type 16, 18 1entecavir 1Tenofovir 1Standard of Care 1Rapid Diagnostic Tests 1Practice Guidelines as Topic 1Hypothermia, Induced 1Enzyme-Linked Immunosorbent Assay 1Engerix-B 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Hepatitis B × Practice Guidelines as Topic × Clear all
NCT03887702 2024-05-20

Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors

SWOG Cancer Research Network

Phase 3 Terminated
4 enrolled 5 charts

Hepatitis B

Data powered by HemOnc (CC BY 4.0) Colophon âš¡